Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
NEUBASE THERAPEUTICS INC
CUSIP: 64132K201
Class: COM NEW
FIRST MANHATTAN CO. LLC.'s Holding History (CIK: 0000728083)
Note: Option positions (PUT/CALL) are excluded.
Q1 2024
Shares
353
Value ($000)
$0
Avg Close
—
Range
—
Q4 2023
Shares
353
Value ($000)
$0
Avg Close
—
Range
—
Q3 2023
Shares
706
Value ($000)
$1
Avg Close
—
Range
—
Q2 2023
Shares
706
Value ($000)
$1
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q1 2024
353
$0
—
—
Q4 2023
353
$0
—
—
Q3 2023
706
$1
—
—
Q2 2023
706
$1
—
—